Jefferies reiterates Humana stock rating on improved MLR results
Investing.com ·
Jefferies reiterates Humana stock rating on improved MLR results
Investing.com - Jefferies reiterated a Buy rating and $420.00 price target on Humana Inc. (NYSE:HUM) shares following the company’s third-quarter results.
The insurance company’s third-quarter Insurance Medical Loss Ratio came in approximately 40 basis points better than management’s guidance, according to Jefferies analyst David Windley. The strong performance has contributed to Humana’s impressive 66% gain over the past year, with shares currently trading at $414.50.
The firm noted that Humana’s fourth-quarter Insurance MLR guidance implies a further steepening of the 2026 MLR curve, which management expected given higher Part D mix and the cadence of certain supplemental benefits.
Read the full story at Investing.com · All coverage of this story